Role of chemotherapy in the treatment of metastatic breast cancer patients
Role of chemotherapy in the treatment of metastatic breast cancer patients
The combined analysis of carfilzomib trials for multiple myeloma
ECHELON-2: Study into brentuximab vedotin and CHP versus CHOP in the frontline treatment of patients with T-Cell lymphomas
Matched targeted therapy for paediatric patients with relapsed, refractory or high-risk leukemias
AMG 330: an anti-CD33 bispecific T-Cell engager antibody construct in relapsed/refractory AML
Landscape change with oral proteasome maintenance in multiple myeloma patients
Patient treatment preferences in relapsed/refractory multiple myeloma
The importance of NF-kB pathway in myeloma
Multiple myeloma highlights and more from ASH 2018
Results of the Beat AML umbrella study for previously untreated acute myeloid leukaemia
ASH 2018: Expert overview of the latest in CLL, ALL and AML
ACT-1: Addition of alemtuzumab to a CHOP backbone for young patients with T-cell lymphoma